Literature DB >> 19050641

Effects of intra-aortic balloon counterpulsation in a model of septic shock.

Steven B Solomon1, Peter C Minneci, Katherine J Deans, Jing Feng, Peter Q Eichacker, Steven M Banks, Robert L Danner, Charles Natanson, Michael A Solomon.   

Abstract

BACKGROUND: Fluid refractory septic shock can develop into a hypodynamic cardiovascular state in both children and adults. Despite management of these patients with empirical inotropic therapy (with or without a vasodilator), mortality remains high.
OBJECTIVES: The effect of cardiovascular support using intra-aortic balloon counterpulsation was investigated in a hypodynamic, mechanically ventilated canine sepsis model in which cardiovascular and pulmonary support were titrated based on treatment protocols.
METHODS: Each week, three animals (n = 33, 10-12 kg) were administered intrabronchial Staphylococcus aureus challenge and then randomized to receive intra-aortic balloon counterpulsation for 68 hrs or no intra-aortic balloon counterpulsation (control). Bacterial doses were increased over the study (4-8 x 10(9) cfu/kg) to assess the effects of intra-aortic balloon counterpulsation during sepsis with increasing risk of death. MAIN
RESULTS: Compared with lower bacterial doses (4-7 x 10(9) colony-forming units/kg), control animals challenged with the highest dose (8 x 10(9) colony-forming units/kg) had a greater risk of death (mortality rate 86% vs. 17%), with worse lung injury ([A - a]O2), and renal dysfunction (creatinine). These sicker animals required higher norepinephrine infusion rates to maintain blood pressure (and higher FIO2) and positive end-expiratory pressure levels to maintain oxygenation (p < or = 0.04 for all). In animals receiving the highest bacterial dose, intra-aortic balloon counterpulsation improved survival time (23.4 +/- 10 hrs longer; p = 0.003) and lowered norepinephrine requirements (0.43 +/- 0.17 microg/kg/min; p = 0.002) and systemic vascular resistance index (1.44 +/- 0.57 dynes/s/cm5/kg; p = 0.0001) compared with controls. Despite these beneficial effects, intra-aortic balloon counterpulsation was associated with an increase in blood urea nitrogen (p = 0.002) and creatinine (p = 0.12). In animals receiving lower doses of bacteria, intra-aortic balloon counterpulsation had no significant effects on survival or renal function.
CONCLUSIONS: In a canine model of severe septic shock with a low cardiac index, intra-aortic balloon counterpulsation prolongs survival time and lowers vasopressor requirements.

Entities:  

Mesh:

Year:  2009        PMID: 19050641      PMCID: PMC2613171          DOI: 10.1097/CCM.0b013e31818727bf

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  35 in total

1.  The experimental use of the diaphragm as an auxiliary myocardium.

Authors:  A KANTROWITZ; W M McKINNON
Journal:  Surg Forum       Date:  1958

2.  Experimental augmentation of coronary flow by retardation of the arterial pressure pulse.

Authors:  A KANTROWITZ
Journal:  Surgery       Date:  1953-10       Impact factor: 3.982

3.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 4.  The intra-aortic balloon pump: a review.

Authors:  G A Maccioli; W J Lucas; E A Norfleet
Journal:  J Cardiothorac Anesth       Date:  1988-06

5.  Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia.

Authors:  Yu-Hui Chiu; Chorng-Kuang How; Chii-Hwa Chern; Lee-Min Wang; Chun-I Huang
Journal:  Am J Emerg Med       Date:  2007-02       Impact factor: 2.469

6.  Plasma electrolyte and metabolite concentrations associated with pentobarbital or pentobarbital-propofol anesthesia during three weeks' mechanical ventilation and intensive care in dogs.

Authors:  G A Gronert; S C Haskins; E P Steffey; D Fung
Journal:  Lab Anim Sci       Date:  1998-10

7.  rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia.

Authors:  B D Freeman; Z Quezado; F Zeni; C Natanson; R L Danner; S Banks; M Quezado; Y Fitz; J Bacher; P Q Eichacker
Journal:  J Appl Physiol (1985)       Date:  1997-11

Review 8.  [The basics of catecholamine therapy. 2. A guide to clinical use].

Authors:  A Gauss; T Anhäupl; W Schütz
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2000-03       Impact factor: 0.698

9.  Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock.

Authors:  Peter C Minneci; Katherine J Deans; Steven M Banks; Renee Costello; Gyorgy Csako; Peter Q Eichacker; Robert L Danner; Charles Natanson; Steven B Solomon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-19       Impact factor: 4.733

10.  Hemodynamic support in fluid-refractory pediatric septic shock.

Authors:  G Ceneviva; J A Paschall; F Maffei; J A Carcillo
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

View more
  5 in total

1.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 2.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08

3.  A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.

Authors:  R Omeir; R Thomas; B Teferedegne; C Williams; G Foseh; J Macauley; L Brinster; J Beren; K Peden; M Breen; A M Lewis
Journal:  Chromosome Res       Date:  2015-05-10       Impact factor: 5.239

Review 4.  The Effect of Sepsis on Myocardial Function: A Review of Pathophysiology, Diagnostic Criteria, and Treatment.

Authors:  Nabeeha Khalid; Pragnesh D Patel; Rahmah Alghareeb; Afshan Hussain; Marvi V Maheshwari
Journal:  Cureus       Date:  2022-06-21

Review 5.  A review of sepsis-induced cardiomyopathy.

Authors:  Ryota Sato; Michitaka Nasu
Journal:  J Intensive Care       Date:  2015-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.